HS
VERA icon

HighVista Strategies’s Vera Therapeutics VERA Stock Holding History

HighVista Strategies’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.79M Buy
+69,241
New +$2.98M 0.77% 44
2025
Q4 		– Sell
-91,189
Closed -$2.65M – 176
2025
Q3 		$2.65M Buy
91,189
+50,716
+125% +$1.17M 0.65% 46
2025
Q2 		$954K Sell
40,473
-11,724
-22% -$264K 0.35% 111
2025
Q1 		$1.25M Hold
52,197
– – 0.48% 95
2024
Q4 		$2.21M Buy
52,197
+30,187
+137% +$1.34M 0.82% 38
2024
Q3 		$973K Buy
22,010
+12,848
+140% +$488K 0.34% 104
2024
Q2 		$331K Buy
+9,162
New +$363K 0.12% 131
2023
Q4 		– Sell
-30,902
Closed -$424K – 149
2023
Q3 		$424K Buy
+30,902
New +$530K 0.2% 125

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return